PDB74 - Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin or Exenatide in Patients With Inadequately Controlled Type 2 Diabetes On Oral Antidiabetic Drugs In Greece
| Autor: | Tzanetakos, C., Melidonis, A., Verras, C., Kourlaba, G., Maniadakis, N. |
|---|---|
| Zdroj: | In Value in Health November 2014 17(7):A345-A345 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect